NCT03101488 2022-03-03
Phase I Study of KN035 in Chinese Subjects With Advanced Solid Tumors
3D Medicines
Phase 1 Completed
Clinical Trials
3 trialsNCT03248843 2022-02-08
A Study of PD-L1 Antibody KN035 in Japanese Subjects With Locally Advanced or Metastatic Solid Tumors
3D Medicines
Phase 1 Completed
NCT02827968 2021-06-02
Phase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid Tumors
3D Medicines
Phase 1 Completed